116
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Perspectives of Healthcare Professionals Towards Combination Use of Oral Paracetamol and Topical Non-Steroidal Inflammatory Drugs in Managing Mild-to-Moderate Pain for Osteoarthritis in a Clinical Setting: An Exploratory Study

ORCID Icon, ORCID Icon, &
Pages 2263-2272 | Received 04 May 2022, Accepted 30 Jul 2022, Published online: 06 Aug 2022

References

  • Perrot S. Osteoarthritis pain: pathophysiology, diagnosis, and management. International Association for the Study of Pain; 2016. Available from: https://s3.amazonaws.com/rdcms-iasp/files/production/public/Content/ContentFolders/GlobalYearAgainstPain2/2016/FactSheets/English/13.%20Osteoarthritis%20Pain.pdf. Accessed August 3, 2022.
  • Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results. Osteoarthritis —level 3 cause. Institute for Health Metrics and Evaluation; 2020 Available from: https://www.healthdata.org/results/gbd_summaries/2019/osteoarthritis-level-3-cause. Accessed August 3, 2022.
  • Nakata K, Tsuji T, Vietri J, Jaffe DH. Work impairment, osteoarthritis, and health-related quality of life among employees in Japan. Health Qual Life Outcomes. 2018;16(64):1–11. doi:10.1186/s12955-018-0896-9
  • DiBonaventura M, da Costa GS, McDonald M, Sadosky A. Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the national health and wellness survey. BMC Musculoskelet Disord. 2011;12(83):1–9. doi:10.1186/1471-2474-12-83
  • Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;120(5):3–6.
  • National Institute for Health and Care Excellence. Osteoarthritis: care and management | clinical Guideline CG177; 2020.
  • Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, Hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. doi:10.1016/j.joca.2019.06.011
  • American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the Knee (NonArthroplasty) Evidence-Based Clinical Practice Guideline; 2021. Available from: https://www.aaos.org/oak3cpg. Accessed August 3, 2022.
  • Primorac D, Molnar V, Matišić V, et al. Comprehensive review of knee osteoarthritis pharmacological treatment and the latest professional societies’ guidelines. Pharmaceuticals. 2021;14(3):205. doi:10.3390/ph14030205
  • Balmaceda CM. Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis. BMC Musculoskelet Disord. 2014;15(27):1–5. doi:10.1186/1471-2474-15-27
  • The Royal Australian College of General Practitioners. Guideline for the management of knee and Hip osteoarthritis (Second edition). East Melbourne, VIc: RACCP; 2018. Available from: https://www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Joint%20replacement/Guideline-for-the-management-of-knee-and-hip-OA-2nd-edition.pdf. Accessed August 3, 2022.
  • Freo U, Ruocco C, Valerio A, Scagnol I, Paracetamol: NE. A review of guideline recommendations. J Clin Med. 2021;10(15):3420. doi:10.3390/jcm10153420
  • Malaysia Health Technology Assessment Section (MaHTAS). Management of osteoarthritis (Second Edition). Malaysia Health Technology Assessment Section (MaHTAS); 2013. Available from: https://www.moh.gov.my/moh/attachments/8933.pdf. Accessed August 3, 2022.
  • Jawad ASM. Analgesics and osteoarthritis: are treatment guidelines reflected in clinical practice? Am J Ther. 2005;12(1):98–103. doi:10.1097/00045391-200501000-00013
  • van den Heuvel J, Koning L, Bogers AJJC, Berg M, van Dijen MEM. An ISO 9001 quality management system in a hospital: bureaucracy or just benefits? Int J Health Care Qual Assur. 2005;18(5):361–369. doi:10.1108/09526860510612216
  • Yoo B, Choi SW, Lee MS, Moon HB. Treatment of knee osteoarthritis with Ketoprofen (Ketotop): a double-blind placebo-controlled randomized trial. J Korean Rheum Assoc. 2015;3(1):70–75.
  • Bruyère O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–350. doi:10.1016/j.semarthrit.2019.04.008
  • Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220–233. doi:10.1002/art.41142
  • Zhang W. The powerful placebo effect in osteoarthritis. Clin Exp Rheumatol. 2019;120(5):118–123.
  • Musila N, Underwood M, McCaskie AW, Black N, Clarke A, van der Meulen JH. Referral recommendations for osteoarthritis of the knee incorporating patients’ preferences. Fam Pract. 2011;28(1):68–74. doi:10.1093/fampra/cmq066
  • Klinge SA, Sawyer GA. Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review. Phys Sportsmed. 2013;41(2):64–74. doi:10.3810/psm.2013.05.2016
  • Zeng C, Doherty M, Persson MSM, et al. Comparative efficacy and safety of Acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthr Cartil. 2021;29(9):1242–1251. doi:10.1016/j.joca.2021.06.004
  • National Collaborating Centre for Chronic Conditions (UK). Osteoarthritis: national clinical guideline for care and management in adults. London: Royal College of Physicians (UK). National Institute for Health and Clinical Excellence: Guidance; 2008. Available from: http://www.ncbi.nlm.nih.gov/books/NBK48984/. Accessed August 3, 2022.
  • Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4):S18–21. doi:10.1016/j.semarthrit.2015.11.007
  • Argoff CE, Gloth FM. Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients. Ther Clin Risk Manag. 2011;7:393–399. doi:10.2147/TCRM.S24458
  • Altman RD. A rationale for combining Acetaminophen and NSAIDs for mild-to-moderate pain - PubMed. Clin Exp Rheumatol. 2004;22:110–117.
  • Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth. 2008;18(10):915–921. doi:10.1111/j.1460-9592.2008.02764.x